当前位置: X-MOL 学术Drug Resist. Updat. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation
Drug Resistance Updates ( IF 15.8 ) Pub Date : 2024-08-12 , DOI: 10.1016/j.drup.2024.101136
Yunru Gu 1 , Tingting Xu 1 , Yuan Fang 1 , Jun Shao 1 , Tong Hu 1 , Xi Wu 2 , Haoyang Shen 1 , Yangyue Xu 1 , Jingxin Zhang 3 , Yu Song 4 , Yang Xia 5 , Yongqian Shu 6 , Pei Ma 7
Affiliation  

As our comprehension of the intricate relationship between cellular senescence and tumor biology continues to evolve, the therapeutic potential of cellular senescence is gaining increasing recognition. Here, we identify chromobox 4 (CBX4), a Small Ubiquitin-related Modifier (SUMO) E3 ligase, as an antagonist of cellular senescence and elucidate a novel mechanism by which CBX4 promotes drug resistance and malignant progression of gastric cancer (GC).

中文翻译:


CBX4 通过诱导 YAP1 SUMOylation 来抵消细胞衰老,使胃癌细胞对化疗脱敏



随着我们对细胞衰老与肿瘤生物学之间复杂关系的理解不断发展,细胞衰老的治疗潜力越来越得到认可。在这里,我们将小泛素相关修饰剂 (SUMO) E3 连接酶 chromobox 4 (CBX4) 确定为细胞衰老的拮抗剂,并阐明了 CBX4 促进胃癌耐药和恶性进展的新机制 (GC)。
更新日期:2024-08-12
down
wechat
bug